Periplocin can also induce the death of esophageal squamous cell carcinoma (ESCC) cells in vivo and in vitro by downregulating Foxp3, increasing the expression of DR4/DR5, and increasing the cells' sensitivity to trial [4]. Here, FOXP3 is linked to esophageal squamous cell carcinoma.